Cullinan Therapeutics, Inc. CGEM Free cash flow yield
Free cash flow yield at other companies
Other financials
Where this comes from
Calculated from Cullinan Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Cullinan Therapeutics, Inc.’s 10-K, filed March 10, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cullinan Therapeutics, Inc.'s free cash flow yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cullinan Therapeutics, Inc.'s free cash flow yield?
- Cullinan Therapeutics, Inc. (CGEM) reported free cash flow yield of -20.5% in Q4 2024.
- How has Cullinan Therapeutics, Inc.'s free cash flow yield changed year-over-year?
- Cullinan Therapeutics, Inc.'s free cash flow yield increased by 33.6% year-over-year, from -30.8% to -20.5%.
- What is the long-term trend for Cullinan Therapeutics, Inc.'s free cash flow yield?
- Over 2 years (2022 to 2024), Cullinan Therapeutics, Inc.'s free cash flow yield has grown at a -12.0% compound annual growth rate (CAGR), from -26.5% to -20.5%.
- What does free cash flow yield mean?
- Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.